The Indian Pharma supports international sourcing of oncology medicines from India for qualified pharmaceutical importers, distributors, hospitals, oncology centers, NGOs and institutional buyers.
Our oncology portfolio can include chemotherapy medicines, targeted therapies, immunotherapies, supportive-care medicines and other cancer-related pharmaceutical products, subject to product availability and applicable regulations.
Buyers can submit requirements for:
We evaluate oncology requirements from international markets based on product availability, manufacturer suitability, regulatory requirements, quantity and destination-country import conditions.
Depending on the product and manufacturer, buyers may require GMP documentation, WHO-GMP records, EU-GMP documentation, U.S. FDA-related information, CPP/COPP, Certificate of Analysis and other applicable regulatory documents.
Documentation is product- and manufacturer-specific.
Hospitals, oncology centers, pharmaceutical distributors, wholesalers, NGOs and government procurement organizations can submit oncology requirements for evaluation.
Where legally permitted, certain oncology medicines may be evaluated through named-patient or special-access pathways. Prescription, import authorization and patient-specific documentation may be required.
Provide the medicine name, strength, dosage form, quantity and destination country for sourcing evaluation.
Requirements can be evaluated according to product availability and destination regulations.
Yes. Hospital and institutional requirements can be evaluated.
Yes, specific requirements can be submitted.
Applicable documents depend on the product and manufacturer.
Where legally permitted, such requirements can be evaluated through the appropriate pathway.
